MetLife Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-49,282
| Closed | -$2.59M | – | 2357 |
|
|
2020
Q3 | $2.59M | Sell |
49,282
-2,576
| -5% | -$135K | 0.03% | 613 |
|
|
2020
Q2 | $1.73M | Buy |
51,858
+3,744
| +8% | +$125K | 0.02% | 786 |
|
|
2020
Q1 | $1.31M | Buy |
48,114
+4,318
| +10% | +$117K | 0.02% | 791 |
|
|
2019
Q4 | $864K | Hold |
43,796
| – | – | 0.01% | 1166 |
|
|
2019
Q3 | $568K | Hold |
43,796
| – | – | 0.01% | 1352 |
|
|
2019
Q2 | $545K | Hold |
43,796
| – | – | 0.01% | 1429 |
|
|
2019
Q1 | $636K | Buy |
43,796
+8,123
| +23% | +$118K | 0.01% | 1310 |
|
|
2018
Q4 | $394K | Hold |
35,673
| – | – | ﹤0.01% | 1520 |
|
|
2018
Q3 | $938K | Hold |
35,673
| – | – | 0.01% | 1159 |
|
|
2018
Q2 | $730K | Buy |
35,673
+3,455
| +11% | +$70.7K | 0.01% | 1180 |
|
|
2018
Q1 | $585K | Hold |
32,218
| – | – | 0.01% | 1282 |
|
|
2017
Q4 | $449K | Buy |
+32,218
| New | +$449K | 0.01% | 1461 |
|